Cowen Group Stock News

Financial Services > Financial - Capital Markets

Buy COWN

*Your capital is at risk

$38.99

+0 (+0%)

At Close: May 26, 2023

Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference

07:00am, Wednesday, 25'th Feb 2026

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for pati

Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference

04:30pm, Tuesday, 24'th Feb 2026

REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibod

Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference

04:05pm, Tuesday, 24'th Feb 2026

REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted c

UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference

04:05pm, Tuesday, 24'th Feb 2026

PRINCETON, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and speci

Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

04:01pm, Tuesday, 24'th Feb 2026

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and h

Medincell to Present at the TD Cowen 46th Annual Healthcare Conference in Boston, March 2-4, 2026

12:00pm, Tuesday, 24'th Feb 2026

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Euronext Paris: MEDCL), a commercial- and clinical-stage biopharmaceutical licensing company developing long-acting injectable treatme

Senti Biosciences to Present at TD Cowen 46th Annual Health Care Conference

09:15am, Tuesday, 24'th Feb 2026

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene

Sarepta Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

08:30am, Tuesday, 24'th Feb 2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fi

Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in Boston

08:05am, Tuesday, 24'th Feb 2026

NEEDHAM, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biologic